Breaking Finance News

HTG Molecular Diagnostics Inc (NASDAQ:HTGM) has been downgraded to Strong Sell in a statement by ValuEngine earlier today.

Boasting a price of $2.42, HTG Molecular Diagnostics Inc (NASDAQ:HTGM) traded 5.71% higher on the day. With the last stock price close down -33.94% from the two hundred day average, compared with the S&P 500 Index which has increased 0.05% over the date range. HTG Molecular Diagnostics Inc has recorded a 50-day average of $2.43 and a two hundred day average of $3.36. Volume of trade was down over the average, with 112,780 shares of HTGM changing hands under the typical 483,839

ValuEngine has downgraded HTG Molecular Diagnostics Inc (NASDAQ:HTGM) to Strong Sell in a statement released on 7/6/2017.

Performance Chart

HTG Molecular Diagnostics Inc (NASDAQ:HTGM)

With a total market value of $0, HTG Molecular Diagnostics Inc has with a one year low of $1.20 and a one year high of $13.25 .

A total of 2 equity analysts have released a research note on HTGM. Two equity analysts rating the company a strong buy, zero equity analysts rating the company a buy, zero equity analysts rating the company a hold, zero equity analysts rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of $7.50.

More About HTG Molecular Diagnostics Inc (NASDAQ:HTGM)

HTG Molecular Diagnostics, Inc. is a commercial-stage company that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The Company's HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications, including tumor profiling, molecular diagnostic testing and biomarker development. The Company's HTG Edge and HTG EdgeSeq platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on a range of biological samples. The Company's HTG EdgeSeq chemistry, together with its HTG Edge or HTG EdgeSeq instrumentation and software, automates and adapts its nuclease protection chemistry to enable analysis using next generation sequencing (NGS) instrumentation. The HTG EdgeSeq system utilizes substantially the same sample preparation reagents as its original chemistry, but allows for read out on an NGS instrument.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.